Clinical Trial Update: Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial exploring the effects of botox on weight loss and glucose tolerance in obese individuals with type 2 diabetes; study terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Obese, Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-02-28